🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 4 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/11/2004 14,10 14,34 12,96 13,20 -6,38% 9,79% 33.983
26/11/2004 12,48 14,28 12,48 14,10 +9,81% 14,42% 51.417
24/11/2004 12,42 12,84 12,36 12,84 +2,39% 3,86% 21.267
23/11/2004 12,42 12,84 12,30 12,54 -2,34% 4,35% 17.883
22/11/2004 12,42 12,90 12,36 12,84 +3,38% 4,35% 25.717
19/11/2004 12,54 12,60 12,36 12,42 -0,96% 1,91% 15.850
18/11/2004 12,66 13,44 12,36 12,54 -0,48% 8,53% 12.200
17/11/2004 12,66 12,84 12,36 12,60 +0,96% 3,79% 29.883
16/11/2004 12,36 12,90 12,24 12,48 -0,95% 5,34% 21.367
15/11/2004 12,90 12,90 12,36 12,60 +2,44% 4,19% 20.633
12/11/2004 12,48 12,60 12,18 12,30 -3,30% 3,37% 33.300
11/11/2004 13,50 13,50 12,60 12,72 -3,20% 6,67% 19.183
10/11/2004 13,26 13,62 12,60 13,14 +7,35% 7,69% 78.033
09/11/2004 12,42 12,42 12,12 12,24 -0,97% 2,42% 20.800
08/11/2004 12,00 12,48 12,00 12,36 +0,49% 4,00% 14.883
05/11/2004 12,54 12,60 12,00 12,30 -0,97% 4,78% 41.817
04/11/2004 12,66 13,32 12,12 12,42 -2,82% 9,48% 53.717
03/11/2004 13,44 13,68 12,60 12,78 -3,18% 8,04% 28.567
02/11/2004 13,20 13,92 11,88 13,20 -5,98% 15,45% 71.150
01/11/2004 14,46 14,94 13,50 14,04 +4,00% 9,96% 102.717
29/10/2004 13,92 15,84 12,96 13,50 +8,70% 20,69% 396.500
28/10/2004 12,36 12,72 12,00 12,42 -1,43% 5,83% 12.433
27/10/2004 12,12 12,72 12,06 12,60 +0,00% 5,45% 17.883
26/10/2004 12,36 12,84 12,24 12,60 +0,96% 4,85% 10.767
25/10/2004 12,90 12,96 12,30 12,48 -3,70% 5,12% 29.217
22/10/2004 13,02 13,38 12,90 12,96 -0,92% 3,69% 15.950
21/10/2004 12,72 13,32 12,66 13,08 +3,81% 5,19% 10.417
20/10/2004 12,60 12,78 12,42 12,60 -1,87% 2,86% 7.433
19/10/2004 12,90 13,38 12,60 12,84 -1,83% 6,05% 12.167
18/10/2004 13,20 13,92 12,90 13,08 -0,91% 7,73% 8.883